EPCAM and breast cancer: Additionally, it has been recently recognized that only EpCAM-negative CTCs in breast cancer patients possess enhanced metastasizing potential to brain [21], though phenotypic existence of EpCAM on metastasis-initiating cells (MICs) among CTC has been demonstrated [22].